# US 2026/0297121 A1 · Mithramycin (mtm) 2’ oximes

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0297121 A1
- Document ID: US20260297121A1
- Status: Published application
- Kind: A1
- Application number: 19/474,614
- Filed: 2024-04-11
- Published: 2026-10-01
- Earliest claimed: 2023-04-11
- Assignees: University of Kentucky Research Foundation
- Applicants: University of Kentucky Research Foundation
- Inventors: Jon S. Thorson; Markos Leggas; Yang Liu; Aarajana Shrestha
- Web page: https://patentgrep.com/patent/US20260297121A1

## CPC

- C07H 15/26: Acyclic or carbocyclic radicals, substituted by hetero rings
- A61K 31/7056: containing five-membered rings with nitrogen as a ring hetero atom
- A61K 31/706: containing six-membered rings with nitrogen as a ring hetero atom
- A61K 31/7064: containing condensed or non-condensed pyrimidines
- A61K 31/7072: having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
- A61P 35/00: Antineoplastic agents
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Compounds described herein are mithramycin (MTM) oxide (OX) derivatives. These compounds are useful for treatment of cancers and neuro-diseases.

## Claims

### Claim 1

A compound having the following formula:
or a pharmaceutically acceptable salt thereof,
wherein R is

### Claim 2 (depends on 1)

A composition comprising the compound of claim 1 and a pharmaceutically-acceptable carrier.

### Claim 3 (depends on 1)

A method of treating cancer or neuro-disease in a patient in need thereof, the method comprising administering to the patient a therapeutically effective amount of the compound of claim 1.

### Claim 4 (depends on 3)

The method of claim 3, wherein the method comprises treating Ewing sarcoma, prostate cancer, colon cancer, lung cancer, leukemia, lymphoma, rhabdomyosarcoma or rhabdoid tumor.

### Claim 5 (depends on 1)

A method for selectively modulating the activity of a target ETS transcription factor in a patient in need thereof, including administering to the patient a therapeutically effective amount of the compound of claim 1.
